| Announce Date | 01/30/2026 |
| EPS Normalized Actual | $-0.06 (Beat by $0.08) |
| EPS GAAP Actual | $-0.06 (Beat by $0.08) |
| Revenue Actual | $0.938B |
| Revenue Surprise | Beat by $938M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.22 |
| EPS GAAP Estimate | $-0.22 |
| Revenue Estimate | $1.629B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | 0.28 | 153.82 | 0.24718 | 0.32687 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -2.08 | -1.93 | 0.938B | 100% | -669M |
| FQ3 2025 (Sep 2025) | -1.79 | -1.8 | 0.931B | -11.82% | -842M |
| FQ2 2025 (Jun 2025) | -10.86 | -10.87 | 1.31748B | 24.93% | -455.52M |
| FQ1 2025 (Mar 2025) | 0 | 0.1 | 0.907B | -24.04% | -653M |
| FQ4 2024 (Dec 2024) | 4.24 | 4.24 | 0B | -INF% | 0M |
| FQ3 2024 (Sep 2024) | -3.75 | -3.75 | 1.041B | 100% | 1041M |
| FQ2 2024 (Jun 2024) | -0.91 | -0.91 | 0.989B | 100% | 989M |
| FQ1 2024 (Mar 2024) | 1.31 | 1.31 | 1.125B | 100% | 1125M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.22
Consensus Revenue Estimates
1.629B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.982 | -- | 0.982 | 0.982 | 1 |
| FQ2 2027 (Jun 2027) | 1.513 | -- | 1.513 | 1.513 | 1 |
| FQ1 2027 (Mar 2027) | 0.772 | -- | 0.772 | 0.772 | 1 |
| FQ4 2026 (Oct 2026) | -0.25 | -732 | -0.25 | -0.25 | 0 |
| FQ3 2026 (Jul 2026) | -0.09 | -1888.89 | -0.09 | -0.09 | 0 |
| FQ2 2026 (Jun 2026) | -0.09 | -11966.67 | -0.09 | -0.09 | 0 |
| FQ1 2026 (Mar 2026) | -0.22 | -- | -0.22 | -0.22 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.98B | -- | 0.98B | 0.98B | 1 |
| FQ2 2027 (Jun 2027) | 0.97B | -- | 0.97B | 0.97B | 1 |
| FQ1 2027 (Mar 2027) | 0.97B | -- | 0.97B | 0.97B | 1 |
| FQ4 2026 (Oct 2026) | 1.7B | 44.82 | 1.7B | 1.7B | 0 |
| FQ3 2026 (Jul 2026) | 1.87B | 50.08 | 1.87B | 1.87B | 0 |
| FQ2 2026 (Jun 2026) | 1.87B | 29.36 | 1.87B | 1.87B | 0 |
| FQ1 2026 (Mar 2026) | 1.63B | 44.32 | 1.63B | 1.63B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
4
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.15 | -2.08 | -1.93 | 92.79% |
| FQ3 2025 (Sep 2025) | 0.01 | -1.79 | -1.8 | 100.56% |
| FQ2 2025 (Jun 2025) | 0.01 | -10.86 | -10.87 | 100.09% |
| FQ1 2025 (Mar 2025) | -0.1 | 0 | 0.1 | INF% |
| FQ4 2024 (Dec 2024) | 4.24 | 4.24 | 100% | |
| FQ3 2024 (Sep 2024) | -3.75 | -3.75 | 100% | |
| FQ2 2024 (Jun 2024) | -0.91 | -0.91 | 100% | |
| FQ1 2024 (Mar 2024) | 1.31 | 1.31 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $1.61B | $0.94B | $-669M | -71.32% |
| FQ3 2025 (Sep 2025) | $1.77B | $0.93B | $-842M | -90.44% |
| FQ2 2025 (Jun 2025) | $1.77B | $1.32B | $-455.52M | -34.58% |
| FQ1 2025 (Mar 2025) | $1.56B | $0.91B | $-653M | -72% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $1.04B | $1041M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.99B | $989M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.13B | $1125M | 100% |